Live Breaking News & Updates on Stealth Biotherapeutics Corp

Stay updated with breaking news from Stealth biotherapeutics corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rare disease company Reneo stops all development

Reneo Pharmaceuticals Inc. is halting development of its only asset, mavodelpar, after a phase IIb study missed its primary and secondary efficacy endpoints. The selective peroxisome proliferator-activated receptor (PPAR)-delta agonist was being developed to treat to rare genetic mitochondrial diseases. ....

Reneo Pharmaceuticals Inc , Reneo Pharmaceuticals , Reneo Pharmaceuticals Inc , Astellas Pharma Inc , Stealth Biotherapeutics Corp , Ppar Delta Agonist , Rare Diseases , Genetic Diseases , Primary Mitochondrial Myopathies ,

Stealth BioTherapeutics Board Receives Preliminary Proposal Letter

(RTTNews) - Stealth BioTherapeutics Corp (MITO) said its Board has received a preliminary proposal letter from Morningside Venture (I) Investments. ....

Stealth Biotherapeutics Corp , Morningside Venturei Investments Ltd , J Wood Capital Advisors , Morningside Venture , Capital Advisors , Special Committee ,